New RNA tool may reveal best heated chemo for rare abdominal cancer
NCT ID NCT06839378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a new method to see how well two different heated chemotherapy regimens work against pseudomyxoma peritonei, a rare abdominal cancer. Researchers injected a special form of chemotherapy (5-FU) before surgery to label newly made RNA in tumor cells. After surgery, patients received either cisplatin alone or cisplatin plus docetaxel as heated chemotherapy. By comparing RNA changes in tumor samples before and after treatment, the study aimed to identify which regimen affects cancer cells more. The 36 participants were adults aged 18-75 with confirmed disease who were eligible for surgery and heated chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 5-fluorouracil, cisplatin, docetaxel
- What this could lead to
- If successful, this could help doctors choose the most effective heated chemotherapy regimen for pseudomyxoma peritonei and identify new treatment targets.
- What could go wrong
- This is a very small, early-stage study (36 people) that only looks at RNA changes, not patient outcomes like survival. The results may not translate into better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOMYXOMA PERITONEI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tsinghua Changgung Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What does recovery really look like after aggressive peritoneal cancer surgery?
- Common diabetes drug may slow rare abdominal cancer
- Lower dose of heated chemo may be just as effective for rare abdominal cancer
- Keeping patients at the right temperature during surgery may protect their brain
- Breathe away the fear: new study tests heart coherence for cancer patients
- New vaccine combo takes on rare belly cancer